Balancing the Benefits of Biologic Therapy for Autoimmune Disease Against the Risks of Mycobacterial Infections

Tumor necrosis factor-α inhibitors (TNFis) have transformed care for rheumatoid arthritis and other autoimmune diseases, but they also are associated with higher risks of serious and opportunistic infections than traditional disease-modifying antirheumatic drugs. In this article, Cassandra Calabrese, DO, discusses balancing the benefits of biologic therapies with the risks of infection.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy

Pregnancy and Rheumatoid Arthritis

Women with rheumatoid arthritis who are of childbearing age face many challenges throughout pregnancy and extending into the postpartum period, from fertility to birth outcomes and control of disease. In this article, rheumatologist Emily Littlejohn, DO, MPH, discusses special considerations for managing patients with rheumatoid arthritis throughout pregnancy and the postpartum period.

Advertising Policy